Kenneth L Londoner founded the medical device company, BioSig Technologies in February 2009. Since then, he serves as the CEO of this company. BioSig has developed the PURE EP System. It is an advanced biomedical signal processing technology designed to treat atrial fibrillation.
In addition, Londoner serves as Managing Partner of Endicott Management Partners, LLC. This firm dedicates to assisting emerging growth companies in their corporate development and investing needs.
During the period between April 2007 and October 2009, Kenneth L Londoner has served as the executive vice president of the Silicon Valley-based cardiac software the company, NewCardio, Inc.
Londoner served a Director and the architect for the turnaround at Alliqua BioMedical, Inc. from May 2012 to March 2014.
Furthermore, Londoner co-founded the port security and logistics company Safe Ports Holdings, LLC, in Charleston, South Carolina. Also, he is a member of the board of Directors of the Safe Ports Board.
Moreover, Londoner was the founder and managing partner of Red Coat Capital Management, founded in late 1996. It is a hedge fund that has grown from its initial base of $ 2 million in assets to a peak of $ 1.1 billion.